Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Angiodynamics (ANGO) Long-Term Debt Repayments (2016 - 2023)

Historic Long-Term Debt Repayments for Angiodynamics (ANGO) over the last 14 years, with Q3 2023 value amounting to $50.0 million.

  • Angiodynamics' Long-Term Debt Repayments rose 1111.11% to $50.0 million in Q3 2023 from the same period last year, while for May 2024 it was $50.0 million, marking a year-over-year increase of 1111.11%. This contributed to the annual value of $50.0 million for FY2024, which is 1111.11% up from last year.
  • According to the latest figures from Q3 2023, Angiodynamics' Long-Term Debt Repayments is $50.0 million, which was up 1111.11% from $45.0 million recorded in Q3 2022.
  • In the past 5 years, Angiodynamics' Long-Term Debt Repayments registered a high of $132.5 million during Q3 2019, and its lowest value of $1.2 million during Q2 2019.
  • Moreover, its 4-year median value for Long-Term Debt Repayments was $11.2 million (2019), whereas its average is $37.1 million.
  • Within the past 5 years, the most significant YoY rise in Angiodynamics' Long-Term Debt Repayments was 1050000.0% (2019), while the steepest drop was 0.0% (2019).
  • Over the past 4 years, Angiodynamics' Long-Term Debt Repayments (Quarter) stood at $132.5 million in 2019, then crashed by 92.45% to $10.0 million in 2021, then surged by 350.0% to $45.0 million in 2022, then increased by 11.11% to $50.0 million in 2023.
  • Its Long-Term Debt Repayments was $50.0 million in Q3 2023, compared to $45.0 million in Q3 2022 and $10.0 million in Q2 2021.